-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – OPC-415 in Relapsed Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPC-415 in Relapsed Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPC-415 in Relapsed Multiple Myeloma Drug Details: OPC-415 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – OPC-415 in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - OPC-415 in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. OPC-415 in Refractory Multiple Myeloma Drug Details: OPC-415 is under development...
-
Product Insights
OPC Rotem Combined Cycle Power Plant
OPC Rotem Combined Cycle Power Plant is a thermal project located in South, Israel. The project is owned by OPC Energy Ltd; Veridis Power Plants Ltd and was developed by OPC Rotem, Ltd.. The project came online in 2013. Empower your strategies with our OPC Rotem Combined Cycle Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day...
-
Product Insights
NewNet Present Value Model: Lineage Cell Therapeutics Inc’s OPC-1
Empower your strategies with our Net Present Value Model: Lineage Cell Therapeutics Inc's OPC-1 report and make more profitable business decisions.Overview Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models. Lineage Cell Therapeutics...
-
Product Insights
NewNet Present Value Model: Novartis AG’s Gevokizumab
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
Sorek B Generation Facility Power Plant
Sorek B Generation Facility Power Plant is a thermal project located in Israel. The project is owned and developed by OPC Sorek 2 Ltd. The project is currently under construction. Empower your strategies with our Sorek B Generation Facility Power Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections...
-
Sector Analysis
Contract Pharmaceutical Dose Manufacturing Industry – Composition, Size, Market Share and Outlook, 2023 Edition
Contract Pharmaceutical Dose Manufacturing Industry Overview The total dose CMO contract revenue in 2022 represented significant growth over 2021 revenue. The growth rate was the highest recorded since 2011 for commercial contract dose manufacturing revenues, and surprisingly adds to the strong growth experienced in 2021, despite demand for COVID-19 vaccines and therapies waning in 2022. The Contract Pharmaceutical Dose Manufacturing Industry report is a comprehensive look at the finished dose contract manufacturing landscape in 2023. It includes an analysis of...
-
Product Insights
Drug Eluting Stents (DES) Pipeline by Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
Drug Eluting Stents (DES) Pipeline Market Report Overview Drug eluting stents (DES) release drugs locally and can be coated with a polymeric material. The Drug Eluting Stents (DES) pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key...
-
Company Profile
Lucky Cement Ltd – Company Profile
Lucky Cement Ltd (LCL), a part of the Yunus Brothers Group, is a manufacturer and supplier of cement. Its cement manufacturing portfolio includes the Ordinary Portland Cement (OPC), clinkers, block cement, and the sulphate resistant cement. Lucky Cement markets products under different brand names such as Lucky Star, Lucky Gold, Lucky Cement (Regular), Lucky Raj, Lucky Block Cement, Lucky Supreme, and Lucky Sulphate Resistant Cement (SRC). The company also operates international production facilities in Iraq and Congo. The company has...
Add to Basket -
Company Profile
J.K. Cement Ltd – Company Profile
J.K. Cement Ltd (JKC) manufactures and sells cement products and building materials. It produces white cement, grey cement, wall putty, waterproof compounds, and tile adhesive. Its portfolio of grey cement comprises ordinary portland cement (OPC), portland slag cement (PSC) and portland pozzolana cement (PPC), JK Super Strong and JK Super Strong Weather Shield Cement. It also provides value-added products such as JK Primaxx, JK Cement Wallmaxx, JK Cement Gypsomaxx, JK Cement Tilemaxx, JK Cement Whitemaxx and JK Cement Shiledmaxx. It...
Add to Basket